130 results on '"Rozados, Viviana"'
Search Results
2. USE OF SODIUM DICHLOROACETATE FOR CANCER TREATMENT: A SCOPING REVIEW.
3. Combined calcitriol and menadione reduces experimental murine triple negative breast tumor
4. Hsp25 and Hsp70 in Rodent Tumors Treated with Doxorubicin and Lovastatin
5. Potential effect of Chloroquine and Propranolol combination to treat colorectal and triple-negative breast cancers
6. Potential effect of Chloroquine and Propranolol combination to treat colorectal and triple-negative breast cancers
7. Screening the use of DCA for the treatment of cancer in adult patients: a scoping review protocol
8. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
9. Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas
10. Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
11. Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance
12. Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition
13. The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression
14. Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model
15. Inhibition ofras oncogene: A novel approach to antineoplastic therapy
16. Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma
17. Abstract 2745: Drug repositioning for triple negative breast and colorectal cancers treatment: Exploring the use of metformin and propranolol
18. Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
19. Achievements and challenges in the use of metronomics for the treatment of breast cancer
20. Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
21. Synthesis of propargylamines via the A3 multicomponent reaction and their biological evaluation as potential anticancer agents
22. Immunotherapy for liver tumors: present status and future prospects
23. Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
24. Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
25. Synthesis of propargylamines via the A3 multicomponent reaction and their biological evaluation as potential anticancer agents.
26. Paclitaxel delivery system based on poly(lactide-co-glycolide) microparticles and chitosan thermo-sensitive gel for mammary adenocarcinoma treatment
27. Abstract 3: Metronomic chemotherapy with cyclophosphamide (Cy) and the repositioned drug losartan (Los) for the treatment of M-234p triple negative murine mammary adenocarcinoma
28. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
29. Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
30. Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models
31. Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
32. Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
33. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
34. Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
35. Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
36. Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model
37. Inmunomodulación y antiangiogénesis en la terapéutica oncológica. De la investigación básica a la clínica
38. A new perspective in cancer treatment: Low dose metronomic chemotherapy with old known drugs in advanced breast cancer patients—Phase II clinical trial.
39. Abstract 795: Metronomic chemotherapy with cyclophosphamide and metformin inhibits tumor and metastasis growth M-406 murine mammary adenocarcinoma
40. A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting
41. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells
42. Abstract 2060: Metronomic chemotherapy (MCT): comparison of the efficacy of two combinations of drugs for the treatment of murine mammary adenocarcinomas.
43. Abstract 4665: VEGF/SVEGFR-2 and VEGF/TSP-1 ratios as probable predictors of response to metronomic chemotherapy with Cyclophosphamide and Celecoxib in advanced breast cancer patients.
44. Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
45. Abstract 701: TUMOR lymphocyte infiltration, expression of CD4, CD8, FOXP3, CD34 molecules and their relationship with tumor evolution after primary treatment in breast cancer patients
46. Abstract 1749: Phase I/II clinical trial: Metronomic chemotherapy with cyclophosphamide (Cy) and celecoxib (Cel) in breast cancer patients progressing after standard chemotherapy
47. Abstract 3552: Cancer immunoediting: Profile of cytokines in a mammary adenocarcinoma tumor model
48. Abstract 5673: Mechanisms responsible for the antitumor effect of metronomic chemotherapy with cyclophosphamide (Cy) and doxorubicin (Dox) in murine tumor models of mammary adenocarcinoma
49. Abstract 3146: The involvement of Foxp3 or CD34 expression and tumor lymphocyte infiltration in the prognosis of breast carcinoma patients
50. Abstract 2390: Growth analysis of M-406 mammary adenocarcinoma in F1 and F2 generations of a cross between resistant and susceptible mice lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.